JWN
53
3
TAP
63
3
ROK
27
3
DTE
38
9
NWS
77
19
SEE
29
4
LOW
49
3
CB
50
3
VTR
55
6
ACN
22
4
PH
62
2
UPS
23
3
CA
25
6
O
30
10
HCA
57
6
CMS
53
6
V
46
2
TRV
45
3
BAC
45
4
HSY
38
4
JWN
53
3
TAP
63
3
ROK
27
3
DTE
38
9
NWS
77
19
SEE
29
4
LOW
49
3
CB
50
3
VTR
55
6
ACN
22
4
PH
62
2
UPS
23
3
CA
25
6
O
30
10
HCA
57
6
CMS
53
6
V
46
2
TRV
45
3
BAC
45
4
HSY
38
4
Financhill
Back

Neurocrine Biosciences Stock Predictions

The key to a $1.3T opportunity

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
31

NBIX
Neurocrine Biosciences

Last Price:
$96.20
Seasonality Move:
9.86%

7 Day Trial

ALL ACCESS PASS

$ 7

Top investors are buying this "unlisted" stock

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.

Neurocrine Biosciences Stock Forecast

  • Over the next 52 weeks, Neurocrine Biosciences has on average historically risen by 28.9% based on the past 28 years of stock performance.
  • Neurocrine Biosciences has risen higher in 16 of those 28 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%
  • Is Neurocrine Biosciences Stock Undervalued?
    The current Neurocrine Biosciences [NBIX] share price is $94.89. The Score for NBIX is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • NBIX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Neurocrine Biosciences Stock Go Up Next Year?

  • Over the next 52 weeks, Neurocrine Biosciences has on average historically risen by 28.9% based on the past 28 years of stock performance.

Neurocrine Biosciences Stock Rating

Sell
31
Neurocrine Biosciences (NBIX) is a Sell

Is Neurocrine Biosciences overpriced?

  • Neurocrine Biosciences has risen higher in 16 of those 28 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%

Neurocrine Biosciences Stock Price History

Is NBIX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBIX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
neurocrine.com

52-Week Data

52-Week High:
157.98
52-Week Low:
84.23

Prediction Charts

Market Cap:
9.5B
Price in USD:
94.89
Volume:
1.7M
Beta:
0.78

Technical Analysis

SMA50:
115.17
SMA100:
124.71
SMA200:
127.92
52-Wk Change:
-29.53%

Stock Predictions

  • Is Neurocrine Biosciences stock public?
    Yes, Neurocrine Biosciences is a publicly traded company.
  • What is the Neurocrine Biosciences stock quote today?
    The Neurocrine Biosciences stock price is 94.89 USD today.
  • How to buy Neurocrine Biosciences stock online?
    You can buy Neurocrine Biosciences shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-26 116.23 114.45 116.23 113.05
Mar-27 114.47 114.00 115.80 113.55
Mar-28 113.36 113.16 114.43 112.15
Mar-31 111.55 110.60 112.60 109.00
Apr-1 110.59 107.00 110.89 106.49
Apr-2 105.94 108.31 108.43 105.78
Apr-3 105.32 102.88 107.53 102.55
Apr-4 99.40 95.65 100.52 93.59
Apr-7 92.90 93.25 96.44 90.33
Apr-8 94.54 87.54 96.00 86.57
Apr-9 85.96 95.28 95.56 84.23
Apr-10 93.17 90.72 94.25 87.70
Apr-11 90.45 90.87 91.28 88.35
Apr-14 94.39 94.89 95.56 92.31

Neurocrine Biosciences Earnings

Neurocrine Biosciences Earnings Report: Per Share Neurocrine Biosciences Earnings Q1 Q2 Q3 and Q4 last year and next year.

Neurocrine Biosciences Forecast Revenue Growth

Neurocrine Biosciences Stock Analysis: Historical quarterly revenues per share for Neurocrine Biosciences and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.10 per share, an increase next quarter of $0.50 per share, a decrease this year of $0.41 per share, and an increase next year of $2.54 per share.

* Neurocrine Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.